Professor of Medicine, Medical College GA
Hematology
Dr. Anand P. Jillella, MD
|
|
Give Review
Dr. Anand P. Jillella practices Hematology. He went to Medical College of Georgia. He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "Philadelphia Magazine" and "Fellow (FACP)". Anand P. Jillella, MD is a published doctor and has 45 publications published. The lastest was: 'Assessment of pulmonary and cardiac function after high dose chemotherapy with BEAM and peripheral blood progenitor cell transplantation.' Anand P. Jillella accepts Medicare payments and is registered with Medicare.gov.
Publications
- Utility and impact of early t(15;17) identification by Fluorescence In Situ Hybridization (FISH) in clinical decision making for patients in Acute Promyelocytic Leukem...
- Administration of anti-thymocyte globulin: a comparison of two protocols.
- Predicting early blast transformation in chronic-phase chronic myeloid Leukemia: Is immunophenotyping the missing link?
- Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple ...
- Recurrent Adult Choroid Plexus Carcinoma Treated with High-Dose Chemotherapy and Syngeneic Stem Cell (Bone Marrow) Transplant.
- Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloprolife...
- Dasatinib induces complete cytogenetic response and loss of F359C in an imatinib resistant chronic myelocytic Leukemia patient.
- Mixed chimerism and Graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; conversion to full donor chimerism.
- A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung Cancer.
- What is the optimum number of CD34+ peripheral blood stem Cells for an autologous transplant?
- Infectious complications in patients receiving mobilization chemotherapy for autologous peripheral blood stem Cell collection.
- Treatment of a patient with end-stage renal Disease with Rituximab: pharmacokinetic evaluation suggests Rituximab is not eliminated by hemodialysis.
- Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML ...
- Amyloidosis, Evans syndrome and management options of lymphoplasmacytic Lymphoma.
- Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell Lymphoma to lethal action of HDAC7-Nur77-based mechanism.
- Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with Acute myeloid leukemia with KIT D816V.
- Cotreatment with vorinostat enhances activity of MK-0457 (VX-680) against Acute and chronic myelogenous leukemia cells.
- Multiple Myeloma associated with lactic acidosis.
- Decitabine as "bridge therapy" to a MUD transplant in relapsed AML postautologous stem Cell transplantation.
- Relapsed Acute myelogenous leukemia occurring after 18 years with recurrent novel chromosomal abnormality t(18;22)(q23;q11.2).
- Acute myelogenous leukemia patients are at low risk for invasive fungal infections after high-dose cytarabine consolidations and thus do not require prophylaxis.
- Second allo-SCT from a different donor can improve severe steroid-resistant gut GVHD.
- Impact of response to thalidomide-, lenalidomide- or bortezomib- containing induction therapy on the outcomes of multiple Myeloma patients undergoing autologous transp...
- Cryptococcal meningitis following autologous stem Cell transplantation in a patient with multiple myeloma.
- Leukemic leptomeningeal involvement in stage 0 and stage 1 chronic lymphocytic Leukemia.
- Adult T-cell Leukemia/lymphoma: a rare case in the USA and review of the literature.
- Tumor lysis syndrome in small cell lung Cancer.
- Successful treatment of an intractable case of hereditary basal Cell carcinoma syndrome with paclitaxel.
- High-dose chemotherapy followed by reinfusion of a high number of CD34+ progenitor cells is frequently associated with development of fever in the postenGraftment period.
- Ototoxicity after high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin followed by stem cell transplantation in patients with breast Cancer.
- AutoImmune thrombocytopenia following autologous hematopoietic cell transplantation: review of literature and treatment options.
- P-glycoprotein expression and multidrug resistance in cutaneous T-cell Lymphoma.
- Non-Hodgkin''s Lymphoma presenting as anasarca: probably mediated by tumor necrosis factor alpha (TNF-alpha).
- Surgery for T4 Breast carcinoma: implications for local control.
- Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with Leukemia.
- Neutropenic infections in 100 patients with non-Hodgkin's Lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell t...
- Assessment of pulmonary and cardiac function after high dose chemotherapy with BEAM and peripheral blood progenitor Cell transplantation.
- Reinstituting warfarin in patients who develop warfarin skin necrosis.
- Early fatal Rhizopus infection on voriconazole prophylaxis following allogeneic stem Cell transplantation.
- Fatal Aspergillus fumigatus and Candida glabrata infections with posaconazole prophylaxis after stem Cell transplantation.
- Rituximab provides durable remission in a patient with refractory aggressive diffuse B-cell Lymphoma failing salvage chemotherapy.
- Plasmablastic Lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome.
- Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with Cancer: a phase III double-blind crossover study (N01CB).
- Investigational drugs targeting FLT3 for Leukemia.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Philadelphia Magazine
- Fellow (FACP)
Education
-
Medical College of Georgia -
Kurnool Medical College
Hospital
-
Georgia Regents Medical Center -
Phoebe Putney Memorial Hospital -
Emory University Hospital
Drug Facts
| NPI NUMBER | 1205946548 | |
| NPPES Provider LastName | JILLELLA | |
| NPPES Provider FirstName | ANAND | |
| NPPES Provider ZIPCode | 309120004 | |
| NPPES Provider State | GA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 521.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 38.0 | |
| Percent Opioid Claims | 7.29 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1205946548 |
| Last Name Of The Provider | JILLELLA |
| First Name Of The Provider | ANAND |
| View All |
Similar Doctors
|
|
Dr. Donald C. Townsend Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard H. Bromer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Hudson, MD |
|
|
Dr. Charles L. Lutcher, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Asha D. Nayak, MD |
|
|
Farrukh T. Awan, MB BS
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arati R. Chand, MD |